Hims & Hers Health inked a deal with Eli Lilly on Friday to sell the company's obesity drugs, further entrenching itself in the GLP-1 space. The post Hims & Hers Surges On 'Surprising And Inevitable' Deal With Eli Lilly appeared first on Investor's Business Daily.
CryptoAlerta — análise de criptomoedas e mercado em tempo real